Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Effects of a rehabilitation programme using a nasal inspiratory restriction device in COPD
Gonzalez-Montesinos JL, Fernandez-Santos JR, Vaz-Pardal C, Ponce-Gonzalez JG, Marin-Galindo A, Arnedillo A
International Journal of Environmental Research & Public Health 2021 Apr;18(8):4207
clinical trial
4/10 [Eligibility criteria: No; Random allocation: Yes; Concealed allocation: No; Baseline comparability: Yes; Blind subjects: No; Blind therapists: No; Blind assessors: No; Adequate follow-up: No; Intention-to-treat analysis: No; Between-group comparisons: Yes; Point estimates and variability: Yes. Note: Eligibility criteria item does not contribute to total score] *This score has been confirmed*

Chronic obstructive pulmonary disease (COPD) patients are characterised for presenting dyspnea, which reduces their physical capacity and tolerance to physical exercise. The aim of this study was to analyse the effects of adding a Feel-Breathe (FB) device for inspiratory muscle training (IMT) to an 8-week pulmonary rehabilitation programme. Twenty patients were randomised into three groups: breathing with FB (FBG), oronasal breathing without FB (ONBG) and control group (CG). FBG and ONBG carried out the same training programme with resistance, strength and respiratory exercises for 8 weeks. CG did not perform any pulmonary rehabilitation programme. Regarding intra group differences in the value obtained in the post-training test at the time when the maximum value in the pre-training test was obtained (post-pre), FBG obtained lower values in oxygen consumption (VO2, mean -435.6 mL/min, Bayes Factor (BF10) > 100), minute ventilation (VE -8.5 L/min, BF10 25), respiratory rate (RR, -3.3 breaths/min, BF10 2), heart rate (HR, -13.7 beats/min, BF10 > 100) and carbon dioxide production (VCO2, -183.0 L/min, BF10 50), and a greater value in expiratory time (Tex, 0.22 s, BF10 12.5). At the maximum value recorded in the post-training test (post-final), FBG showed higher values in the total time of the test (Tt, 4.3 min, BF10 50) and respiratory exchange rate (RER, 0.05, BF10 1.3). Regarding inter group differences at pre-post, FBG obtained a greater negative increment than ONBG in the ventilatory equivalent of CO2 (EqCO2, -3.8 L/min, BF10 1.1) and compared to CG in VE (-8.3 L/min, BF10 3.6), VCO2 (-215.9 L/min, BF10 3.0), EqCO2 (-3.7 L/min, BF10 1.1) and HR (-12.9 beats/min, BF10 3.4). FBG also showed a greater pre-post positive increment in Tex (0.21 s, BF10 1.4) with respect to CG. At pre-final, FBG presented a greater positive increment compared to CG in Tt (4.4 min, BF10 3.2) and negative in VE/VCO2 intercept (-4.7, BF10 1.1). The use of FB added to a pulmonary rehabilitation programme in COPD patients could improve tolerance in the incremental exercise test and energy efficiency. However, there is only a statically significant difference between FBG and ONBG in EqCO2. Therefore, more studies are necessary to reach a definitive conclusion about including FB in a pulmonary rehabilitation programme.

Full text (sometimes free) may be available at these link(s):      help